enGene Therapeutics Inc. (ENGN)

NCM – Real Time Price. Currency in USD

1.75

-0.07 (-3.57%)

Market open: Aug 12, 2026, 11:28 AM EDT

1.81

-0.01 (-0.55%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-509K

-323K

-175K

Gross Profit

-509K

-323K

-175K

Operating expenses (excl. COGS)

-123M

-62M

-26M

-2M

Operating Income

-123M

-62M

-26M

-2M

Non-operating income, total

-74M

Pretax income

-117M

-55M

-100M

31K

Equity in earnings

Taxes

19K

-17K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-117M

-55M

-100M

31K

Discontinued operations

Net income

-117M

-55M

-100M

31K

Dilution adjustment

Preferred dividends

enGene Therapeutics Inc. (ENGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

enGene Therapeutics Inc. (ENGN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

enGene Therapeutics Inc. (ENGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

enGene Therapeutics Inc. (ENGN)

Income Statement (Annual)

Income Statement (Annual)